Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Dec-23 4:30 PM View:  | Generation Bio Co. (GBIO) | 01-Dec-23 | Private Purchase | 88,495 | $1.41 | $124,778.00 | 121% 72.84K to 161.33K | |
| 18-Mar-22 6:46 AM View: | Spyre Therapeutics, Inc. (SYRE) | 16-Mar-22 | Private Purchase | 80,079 | $2.34 | $187,705.00 | 11% 736.76K to 816.84K | |
| 15-Mar-22 6:32 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Mar-22 | Purchase | 42,417 | $1.86 | $78,942.30 | 6% 697.34K to 739.76K | |
| 15-Mar-22 6:32 PM View: | Spyre Therapeutics, Inc. (SYRE) | 14-Mar-22 | Purchase | 67,472 | $1.93 | $130,221.00 | 11% 629.87K to 697.34K | |
| 15-Mar-22 6:32 PM View: | Spyre Therapeutics, Inc. (SYRE) | 11-Mar-22 | Private Purchase | 34,777 | $2.06 | $71,779.70 | 6% 595.09K to 629.87K | |
| 13-Dec-21 8:39 PM View: | Spyre Therapeutics, Inc. (SYRE) | 10-Dec-21 | Purchase | 10,526 | $3.75 | $39,472.50 | 2% 584.56K to 595.09K | |
| 13-Dec-21 8:39 PM View: | Spyre Therapeutics, Inc. (SYRE) | 09-Dec-21 | Private Purchase | 43,108 | $3.70 | $159,500.00 | 8% 541.46K to 584.56K | |
| 29-Oct-21 4:01 PM View: | Generation Bio Co. (GBIO) | 28-Oct-21 | Gift | 72,837 | -- | -- | 100% 72.84K to 145.67K | |
| 29-Oct-21 4:01 PM View: | Generation Bio Co. (GBIO) | 28-Oct-21 | Gift | 72,837 | -- | -- | (50%) 145.67K to 72.84K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 20-Oct-21 | Gift | 10,000 | -- | -- | 2% 595.09K to 605.09K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 20-Oct-21 | Gift | 10,000 | -- | -- | (2%) 605.09K to 595.09K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 18-Oct-21 | Gift | 23,809 | -- | -- | 4% 595.09K to 618.9K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 18-Oct-21 | Gift | 23,809 | -- | -- | (4%) 618.9K to 595.09K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 14-Oct-21 | Gift | 175,036 | -- | -- | 29% 595.09K to 770.13K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 14-Oct-21 | Gift | 175,036 | -- | -- | (23%) 770.13K to 595.09K | |
| 18-Jun-20 5:31 PM View: | Generation Bio Co. (GBIO) | 16-Jun-20 | Conversion | 30,376 | -- | -- | 72% 42.46K to 72.84K | |
| 04-May-20 7:30 AM View: | Spyre Therapeutics, Inc. (SYRE) | 30-Apr-20 | Private Purchase | 165,000 | $4.75 | $783,750.00 | 44% 373.47K to 538.47K | |
| 07-Oct-19 4:09 PM View: | Spyre Therapeutics, Inc. (SYRE) | 04-Oct-19 | Option Exercise | 18,265 | $6.28 | $114,689.00 | 5% 353.64K to 371.91K | (2%) |
| 14-Jun-19 5:22 PM View: | Spyre Therapeutics, Inc. (SYRE) | 14-Jun-19 | Market Purchase | 5,282 | $6.23 | $32,912.70 | 2% 348.36K to 353.64K | (1%) |
| 14-Jun-19 5:22 PM View: | Spyre Therapeutics, Inc. (SYRE) | 13-Jun-19 | Market Purchase | 14,406 | $6.17 | $88,836.00 | 4% 333.95K to 348.36K | (< 1%) |
| 14-Jun-19 5:22 PM View: | Spyre Therapeutics, Inc. (SYRE) | 12-Jun-19 | Market Purchase | 12,217 | $6.11 | $74,704.50 | 4% 321.74K to 333.95K | < 1% |
| 22-May-19 4:55 PM View: | Spyre Therapeutics, Inc. (SYRE) | 22-May-19 | Market Purchase | 3,809 | $6.86 | $26,128.20 | 1% 317.93K to 321.74K | < 1% |
| 22-May-19 4:55 PM View: | Spyre Therapeutics, Inc. (SYRE) | 21-May-19 | Market Purchase | 13,794 | $6.89 | $94,981.40 | 5% 304.13K to 317.93K | < 1% |
| 22-May-19 4:55 PM View: | Spyre Therapeutics, Inc. (SYRE) | 20-May-19 | Market Purchase | 8,989 | $6.55 | $58,922.90 | 3% 295.15K to 304.13K | 6% |
| 17-May-19 5:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 17-May-19 | Market Purchase | 6,218 | $6.65 | $41,335.40 | 2% 288.93K to 295.15K | |
| 17-May-19 5:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 16-May-19 | Market Purchase | 5,520 | $6.83 | $37,690.60 | 2% 283.41K to 288.93K | |
| 17-May-19 5:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-May-19 | Market Purchase | 6,256 | $6.76 | $42,269.30 | 2% 277.15K to 283.41K | |
| 04-Mar-19 8:13 PM View: | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 12,853 | -- | -- | 69% 18.75K to 31.6K | |
| 17-May-19 5:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Feb-19 | Private Purchase | 719 | $7.10 | $5,103.46 | < 1% 276.43K to 277.15K | |
| 08-Feb-19 4:15 PM View: | Spyre Therapeutics, Inc. (SYRE) | 06-Feb-19 | Option Exercise | 8,756 | $6.18 | $54,125.80 | 3% 267.68K to 276.43K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 28-Dec-18 | Gift | 57,450 | -- | -- | 14% 420.05K to 477.5K | |
| 14-Feb-22 10:00 PM View: | Spyre Therapeutics, Inc. (SYRE) | 28-Dec-18 | Gift | 57,450 | -- | -- | (12%) 477.5K to 420.05K | |
| 10-Dec-18 5:40 PM View: | Spyre Therapeutics, Inc. (SYRE) | 07-Dec-18 | Option Exercise | 171,890 | $4.37 | $751,816.00 | 179% 95.79K to 267.68K | |
| 10-Dec-18 5:40 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Aug-18 | Market Purchase | 994 | $9.13 | $9,075.22 | 1% 94.79K to 95.79K | (9%) |
| 16-Jul-18 9:04 AM View: | Spyre Therapeutics, Inc. (SYRE) | 12-Jul-18 | Option Exercise | 38,866 | $6.76 | $262,764.00 | 72% 53.93K to 92.79K | (4%) |
| 13-Jul-18 9:05 AM View: | Spyre Therapeutics, Inc. (SYRE) | 11-Jul-18 | Option Exercise | 3,307 | $5.46 | $18,056.20 | 7% 50.62K to 53.93K | |
| 20-Feb-18 4:36 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Feb-18 | Option Exercise | 15,211 | $5.46 | $83,052.10 | 43% 35.41K to 50.62K | |
| 10-Dec-18 5:40 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Feb-18 | Market Purchase | 2,000 | $6.02 | $12,040.00 | 2% 92.79K to 94.79K | 39% |
| 08-Dec-17 7:06 PM View: | Spyre Therapeutics, Inc. (SYRE) | 08-Dec-17 | Market Purchase | 600 | $5.07 | $3,039.00 | 2% 34.81K to 35.41K | 65% |
| 08-Dec-17 7:06 PM View: | Spyre Therapeutics, Inc. (SYRE) | 07-Dec-17 | Market Purchase | 2,800 | $4.99 | $13,967.00 | 9% 32.01K to 34.81K | 67% |
| 08-Dec-17 7:06 PM View: | Spyre Therapeutics, Inc. (SYRE) | 06-Dec-17 | Market Purchase | 4,888 | $4.92 | $24,072.40 | 18% 27.12K to 32.01K | 69% |
| 05-Dec-17 9:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 05-Dec-17 | Market Purchase | 5,065 | $4.93 | $24,975.50 | 23% 22.06K to 27.12K | 69% |
| 05-Dec-17 9:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 04-Dec-17 | Market Purchase | 7,956 | $4.98 | $39,624.10 | 56% 14.1K to 22.06K | 68% |
| 05-Dec-17 9:04 PM View: | Spyre Therapeutics, Inc. (SYRE) | 01-Dec-17 | Market Purchase | 4,100 | $4.53 | $18,577.90 | 41% 10.0K to 14.1K | 84% |
| 12-Apr-16 5:10 PM View: | Spyre Therapeutics, Inc. (SYRE) | 12-Apr-16 | Purchase | 10,000 | $10.00 | $100,000.00 | 100% 0 to 10.0K | |
| 23-Jun-15 10:41 AM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Grant | 38 | $78.87 | $2,997.06 | < 1% 32.64K to 32.67K | |
| 23-Jun-15 10:41 AM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Disposition | 32,675 | -- | -- | (100%) 32.67K to 0 | |
| 09-Jun-15 6:10 PM View: | Trimeris Inc. (GEVA) | 05-Jun-15 | Grant | 27,000 | -- | -- | 479% 5.64K to 32.64K | |
| 29-Apr-15 5:28 PM View: | Trimeris Inc. (GEVA) | 27-Apr-15 | Option Exercise | 10,000 | $1.70 | $17,000.00 | 177% 5.64K to 15.64K | |
| 29-Apr-15 5:28 PM View: | Trimeris Inc. (GEVA) | 27-Apr-15 | Market Option Sale (Planned) | 10,000 | $110.00 | $1,100,000.00 | (64%) 15.64K to 5.64K | (114%) |